Back to News
Market Impact: 0.25

Notable Tuesday Option Activity: WLY, VERV, NDSN

VERVNDSNWLYDCILYELFLRTNDAQ
Derivatives & VolatilityFutures & OptionsCompany FundamentalsHealthcare & BiotechMarket Technicals & Flows
Notable Tuesday Option Activity: WLY, VERV, NDSN

Verve Therapeutics (VERV) experienced unusually high options trading volume, reaching 277.9% of its average daily volume, with significant activity in the $10 strike put option expiring November 2025; similarly, Nordson Corp. (NDSN) saw options volume at 191% of its average, driven by activity in the $200 strike call option expiring June 2025, indicating increased speculative interest in both companies.

Analysis

Verve Therapeutics (VERV) experienced a significant surge in options trading activity, with volume reaching 81,634 contracts, equivalent to approximately 8.2 million underlying shares and representing 277.9% of its recent average daily share volume of 2.9 million shares. Notably, the $10 strike put option expiring November 21, 2025, saw substantial trading of 27,909 contracts, corresponding to about 2.8 million underlying shares, indicating considerable interest in this specific downside protection or bearish position with a long-term horizon. Concurrently, Nordson Corp. (NDSN) also observed elevated options volume at 8,328 contracts, or approximately 832,800 underlying shares, which is 191% of its recent average daily share volume of 436,035 shares. For NDSN, the $200 strike call option expiring June 20, 2025, was particularly active, with 4,159 contracts traded, representing about 415,900 underlying shares, suggesting heightened speculative interest in the stock's upside potential. Despite this increased activity in specific option contracts for both companies, the general sentiment and per-ticker sentiment signals provided are neutral, implying the market has not yet formed a strong directional consensus based on these flows or that the activity reflects diverse strategic motivations rather than a singular market view.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo